Medicare

Politics John Wilkerson

STAT Plus: Medicare scrambles to keep prescription drug plan premiums stable ahead of elections

Politics John Wilkerson

STAT Plus: How to tell if Biden drove a hard bargain in Medicare drug price negotiations

Health tech Mario Aguilar

STAT Plus: Disruptions loom for telehealth providers and patients as Congress inches closer to deadline

First Opinion Melissa Batchelor and Diana J. Mason

Without federal oversight, nursing homes will put profit ahead of care

Health tech Mario Aguilar

STAT Plus: Six questions about Medicare’s proposed plan to cover digital therapeutics

A STAT Investigation Bob Herman, Tara Bannow, Casey Ross, and Lizzy Lawrence

STAT Plus: Health Care's Colossus: How UnitedHealth harnesses its physician empire to squeeze profits out of patients

Video Hyacinth Empinado

How insurers use doctors to profit off medical codes

First Opinion Melissa Barber, Joseph S. Ross, and Reshma Ramachandran

STAT Plus: To get a fair deal on Wegovy, buying Novo Nordisk might not be Medicare’s worst option

Politics Sarah Owermohle and Rachel Cohrs Zhang

STAT Plus: Harris health care agenda swiftly hailed by progressives and reproductive rights groups

Politics Rachel Cohrs Zhang and Sarah Owermohle

STAT Plus: Kamala Harris, endorsed by Biden to replace him, is left of the president on health care

Letters to the editor Patrick Skerrett

Readers respond to essays on philanthropy and nursing schools, opioid overdoses, and more

D.C. Diagnosis Rachel Cohrs Zhang

STAT Plus: Here come Medicare’s first negotiated drug prices

Health Care Inc. Bob Herman

STAT Plus: Medicare pay proposals are good news for health tech, bad news for docs

Politics John Wilkerson

STAT Plus: The effort to reform physician pay is set to pit primary care docs against highly paid specialists

First Opinion Peter Rheinstein

Medicare drug pricing rules will delay access to promising therapies

Health tech Mario Aguilar

STAT Plus: Medicare proposes to cover some digital therapies in a breakthrough for health tech firms

Politics Sarah Owermohle and Rachel Cohrs Zhang

STAT Plus: Trump’s 2024 platform abandons calls to cut Medicare, broadly restrict abortion

Health Care Inc. Bob Herman

STAT Plus: Pulling back the curtain on psychiatric hospital joint ventures

Politics Rachel Cohrs Zhang

STAT Plus: Judge rules against Boehringer Ingelheim in pharma’s latest legal loss on Medicare negotiation

D.C. Diagnosis Sarah Owermohle

STAT Plus: Making sense of the debate’s health care debate

First Opinion Alissa S. Chen

Medicare should wait on approving coverage for new obesity drugs

Health Isabella Cueto

STAT Plus: Medicare’s big experiment to fix kidney failure care hasn’t worked so far, studies say

The Readout Meghana Keshavan

STAT Plus: Will Medicare finally begin covering weight loss drugs like Zepbound and Wegovy?

First Opinion Annette Ansong, Rachel Bond, and Tiffany Powell-Wiley

Medicare’s Part D policy is blocking progress needed to achieve Black health equity

Politics Rachel Cohrs Zhang, John Wilkerson, and Lizzy Lawrence

STAT Plus: House panel passes bills to expand Medicare obesity drug coverage, cancer screening

The Readout Elaine Chen

STAT Plus: Exclusive: European VC Forbion hires Dyne CEO, expands in US

Politics Rachel Cohrs Zhang

STAT Plus: House panel proposes new strategy for Medicare to cover weight loss drugs Wegovy, Zepbound

D.C. Diagnosis Sarah Owermohle

STAT Plus: Senators push Medicare for a PET scan pay bump

Exclusive John Wilkerson and Rachel Cohrs Zhang

STAT Plus: House panel weighs new plan for Medicare coverage of Wegovy, cancer blood tests